Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REFILE-UPDATE 2-'Green is good' says UK's Johnson, wooing Wall Street dollars

Tue, 19th Oct 2021 11:28

(Refiles to remove extraneous word from lead)

* UK announces 9.7 bln pounds of green investment

* Johnson seeks to harness trillions of the markets

* UK to partner with Bill Gates on emerging green tech

By William James

LONDON, Oct 19 (Reuters) - British Prime Minister Boris
Johnson announced nearly 10 billion pounds ($13.72 billion) of
private investment in green projects on Tuesday and courted the
"trillions of the markets" in a speech to the world's top
financiers and executives.

The government's Global Investment Summit in London marks
post-Brexit Britain's biggest push to woo investors, even
leveraging the soft power of drinks with Queen Elizabeth at her
castle, as it seeks cash and partners to get ahead in the
international race for green technology.

"We need urgent government action, but we must mobilise the
markets, we must bring in the private sector," Johnson said in
an opening address on meeting the challenge of climate change.

"You in this room, you can deploy trillions - indeed I'm
given to understand that there's $24 trillion represented in
this room - ... and so I want to say to each and every one of
those dollars: you're very welcome in the UK."

The government announced private investment deals worth 9.7
billion pounds, including 6 billion pounds in offshore wind from
Iberdrola, as well as for net zero carbon warehouses
and decarbonisation technology for the waste industry.

Johnson and Microsoft co-founder Bill Gates announced a 400
million pound joint investment partnership, targeting
technologies such as green hydrogen, long-term energy storage
and sustainable aviation fuels.

"We will scale those up and bring down that cost, so we'll
get these to the same place we are today with solar and onshore
wind, and so they can be scaled up to reduce emissions," Gates
said, speaking alongside Johnson.

Making the case for investment in Britain, Johnson adapted
the "Greed is Good" credo of Gordon Gekko, the fictional banker
from 1980s film "Wall Street".

"Green is good, green is right, green works," he said.

Attendees at the event at London's Science Museum included
JPMorgan Chase & Co Chief Executive Jamie Dimon,
Blackrock CEO Larry Fink and bosses from GlaxoSmithKline
and Darktrace.

Officials hope the summit will bring a new wave of
investments over the next 12 months. More than 100 private
meetings were set to take place in exhibition halls adorned with
planes, spacecraft and other artefacts of Britain's engineering
history.

DRINKS WITH THE QUEEN

France has held a similar investment summit in recent years.

After the conference, attendees will travel to Windsor
Castle for a reception attended by the queen and other senior
royals.

"This summit is not just a showcase, but an opportunity to
come together and, in the generous spirit of collaboration,
forge new partnerships," the queen said in a foreword for the
investment programme.

Britain's green credentials are in the spotlight two weeks
before it hosts the U.N. COP26 climate summit, where Johnson
will try to broker a complex international deal to stall rising
global temperatures.

He played down fears that some important players, including
the leaders of China and Russia, would not attend COP26. China's
climate envoy will attend the summit but it has been reported
that President Xi Jinping will not.

The government said last year it would prioritise green
technology and climate goals in Britain's economic recovery from
the COVID-19 pandemic.

That gambit is central to Johnson's political agenda too: he
was elected in 2019 on a pledge to reinvigorate post-industrial
regions and create higher-skilled, better-paid jobs.

As part of its push for greener technology, the government
said on Tuesday it would increase to 5,000 pounds grants
available to homeowners to remove their gas boilers and replace
them with alternative home heating systems such as heat pumps.
($1 = 0.7290 pounds)

(Reporting by William James; Editing by Alex Richardson and
Catherine Evans)

More News
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.